Bank Of America Corp Vertex Pharmaceuticals Inc Transaction History
Bank Of America Corp
- $1.06 Trillion
- Q1 2024
A detailed history of Bank Of America Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Bank Of America Corp holds 2,544,638 shares of VRTX stock, worth $1.23 Billion. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,544,638
Previous 2,435,920
4.46%
Holding current value
$1.23 Billion
Previous $991 Million
7.32%
% of portfolio
0.1%
Previous 0.1%
Shares
11 transactions
Others Institutions Holding VRTX
# of Institutions
1,625Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12.3 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$10.9 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.6 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.79 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.42 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $124B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...